1. Home
  2. FNWB vs LONA Comparison

FNWB vs LONA Comparison

Compare FNWB & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$11.01

Market Cap

96.3M

Sector

Finance

ML Signal

HOLD

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$7.74

Market Cap

81.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNWB
LONA
Founded
1923
2011
Country
United States
United States
Employees
N/A
19
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.3M
81.5M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FNWB
LONA
Price
$11.01
$7.74
Analyst Decision
Buy
Buy
Analyst Count
1
1
Target Price
$13.50
$10.00
AVG Volume (30 Days)
21.4K
28.2K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
0.70%
N/A
EPS Growth
36.00
N/A
EPS
0.04
N/A
Revenue
$176,000.00
N/A
Revenue This Year
$19.24
N/A
Revenue Next Year
$8.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.05
$4.21
52 Week High
$12.52
$14.21

Technical Indicators

Market Signals
Indicator
FNWB
LONA
Relative Strength Index (RSI) 40.42 48.64
Support Level $9.37 $6.86
Resistance Level $11.51 $9.78
Average True Range (ATR) 0.37 0.45
MACD -0.16 0.06
Stochastic Oscillator 4.59 85.16

Price Performance

Historical Comparison
FNWB
LONA

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: